Diffuse parenchymal lung disease

Medicine

Volumn 36, Issue 5, 2008, Pages 265-272

  Maher, Toby M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

diffuse parenchymal lung disease; idiopathic pulmonary fibrosis; interstitial lung disease; pneumonia; sarcoidosis

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; AZATHIOPRINE; BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OXYGEN; PREDNISOLONE; PROGESTERONE; RAPAMYCIN; SILDENAFIL;

ALLERGIC PNEUMONITIS; ANAMNESIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE PARENCHYMAL LUNG DISEASE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MEGADOSE; DYSPNEA; FAMILY HISTORY; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; LOEFFLER PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG INFILTRATE; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 42649126070     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2008.02.003     Document Type: Review

References (12)

1. K.R. Flaherty A.C. Andrei S. Murray Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute- walk test Am J Respir Crit Care Med 174 2006 803 809
2. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 165 2002 277 304
3. J. Gribbin R.B. Hubbard I. Le Jeune C.J. Smith J. West L.J. Tata Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax 61 2006 980 985
4. T.M. Maher A.U. Wells G.J. Laurent Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 30 2007 835 839
5. M. Selman T.E. King A. Pardo Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 134 2001 136 151
6. M. Demedts J. Behr R. Buhl High-dose N-acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 2005 2229 2242
7. H.R. Collard K.J. Anstrom M.I. Schwarz D.A. Zisman Sildenafil improves walk distance in idiopathic pulmonary fibrosis Chest 131 2007 897 899
8. D.P. Tashkin R. Elashoff P.J. Clements Cyclophosphamide versus placebo in scleroderma lung disease N Engl J Med 354 2006 2655 2666
9. R. Lazor A. Vandevenne A. Pelletier P. Leclerc I. Court-Fortune J.F. Cordier Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d’Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM“O”P) Am J Respir Crit Care Med 162 2000 571 577
10. A. Tazi Adult pulmonary Langerhans’ cell histiocytosis Eur Respir J 27 2006 1272 1285
11. A.M. Taveira-DaSilva M.P. Stylianou C.J. Hedin O. Hathaway J. Moss Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone Chest 126 2004 1867 1874
12. S.R. Johnson Lymphangioleiomyomatosis Eur Respir J 27 2006 1056 1065